Work

Supplementary Figure 4 from Combination of Anti-HER3 Antibody MM-121/SAR256212 and Cetuximab Inhibits Tumor Growth in Preclinical Models of Head and Neck Squamous Cell Carcinoma

Year: 2023
Type: supplementary-materials
Abstract: PDF file - 143KB, The CM combination inhibits PI3K/AKT and ERK signaling pathways.
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: gold
OpenAlex ID: W4362526186
Cites:
Cited by:
Related to: 10